Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Washington Marriott Hotel

Apr 15, 2013 8:30 AM - Apr 17, 2013 12:00 PM

1221 22nd Street NW, , Washington, DC 20037-1294 , USA

CMC Workshop: From Drug Development to Global Supply to Patients

Session 2B: Pharmacopoeias: Collaboration Across Borders

Session Chair(s)

Erin  Wang, MS, RAC

Erin Wang, MS, RAC

Associate Consultant – Compendial Affairs, Global Quality Laboratory

Eli Lilly and Company, US, United States

Pharmacopeias are recognized sources of public standards for pharmaceutical products, ingredients, components, and agreed common practices. Compendial standards are typically comprised of test procedures and associated acceptance criteria. These standards are enforced by regulatory agencies, and are quality standards to be met by all manufacturers/applicants for certain territories. Companies that wish to market products globally must have a robust strategy for meeting compendial requirements for each market. Collaboration between regulators, industry, and pharmacopeias is crucial to ensure that these standards serve to benefit public health, both regionally and internationally. This session will provide an overview of the United States and European compendial science activities. The industry presentation will share experiences in managing public standard implementation globally. Panel discussion will allow participants to have deeper interactions with the speakers and the fellow participants.

Speaker(s)

Shawn  Dressman, PhD

USP Compendial Activites

Shawn Dressman, PhD

United States Pharmacopeia, United States

Vice President, Chemical Medicines, USP-NF

Michael  Wierer, DrSc

European Pharmacopoeia Overview (presentation will be delivered via webinar)

Michael Wierer, DrSc

European Directorate for the Quality of Medicines and HealthCare, France

Head, Biological Standardisation, OMCL Network, Blood Transfusion and Transplant

Craig  Hamilton, PhD

Compendial Affairs

Craig Hamilton, PhD

Eli Lilly and Company, United States

Director - Operational Excellence, Global Quality Laboratory

Erin  Wang, MS, RAC

Compendial Affairs

Erin Wang, MS, RAC

Eli Lilly and Company, US, United States

Associate Consultant – Compendial Affairs, Global Quality Laboratory

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.